Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271707 · ClinicalTrials.gov registry record · Phase 4
Stellate Ganglion Block
A Phase 4 study of Esophagectomy and Lobectomy, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06271707 is a Phase 4 study of Esophagectomy and Lobectomy that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 48 participants, below the 2,131-participant average among 7 other Esophagectomy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06271707, a Phase 4 study of Esophagectomy and Lobectomy, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Conditions Studied
Interventions
- OTHER Saline
- DRUG 0.5% bupivacaine
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2027-07-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06271707
The ClinicalTrials.gov registry entry for NCT06271707 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,131-participant average among 7 other Esophagectomy trials with a reported enrollment target (98% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Esophagectomy appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT06271707 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06271707 about?
NCT06271707 is a clinical study titled "Stellate Ganglion Block". The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
What is the current status of trial NCT06271707?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2025-05-19. Estimated completion is 2027-07-15.
What conditions does trial NCT06271707 study?
This clinical trial studies the following conditions: Esophagectomy, Lobectomy, Pneumonectomy.
What interventions are being tested in trial NCT06271707?
The interventions under investigation include: Saline (OTHER), 0.5% bupivacaine (DRUG).
Who is sponsoring clinical trial NCT06271707?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06271707 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophagectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prevention of Atrial Fibrillation Following Esophagectomy
COMPLETED · Phase 4
-
Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
RECRUITING
-
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
RECRUITING · Phase 2
-
Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
RECRUITING
-
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
RECRUITING
-
Mayo Clinic Upper Digestive Disease Survey
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.